Product Information
ACETAMINOPHEN-COD #4 TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.3809 per EA under NDC 64380044702. Its NADAC has been published 114 times since Jun 19, 2024.
FDA first approved this application on Sep 30, 1988. Its Orange Book therapeutic-equivalence code is AA.
Strength
300; 60 mg/1; mg/1
Manufacturer
Strides Pharma Inc.NDC
64380044702
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; CODEINE PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA089828FDA Approved
9/30/1988
TE Code
AA
On Market Since
5/20/2024
Pharmacological Classes
Price Statistics
The NADAC for ACETAMINOPHEN-COD #4 TABLET has been published 114 times since Jun 19, 2024, and over the history we have for it it has declined 21.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3809 per EA |
|---|---|
| All-time high | $0.4850 (Jul 10, 2024) |
| All-time low | $0.3472 (Nov 20, 2024) |
| 52-week high | $0.4473 |
| 52-week low | $0.3774 |
| Median price | $0.4247 |
| Average price | $0.4216 |
| Largest weekly change | -27.6% (Nov 20, 2024) |
| Weeks tracked | 114 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN-COD #4 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN-COD #4 TABLET, manufactured by Strides Pharma Inc., is $0.3809 per EA (NDC 64380044702), effective Aug 19, 2026.
How has the price of ACETAMINOPHEN-COD #4 TABLET changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN-COD #4 TABLET has declined 21.5%. It has been tracked across 114 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN-COD #4 TABLET?
Since Jun 19, 2024, the NADAC for ACETAMINOPHEN-COD #4 TABLET has ranged from a low of $0.3472 (Nov 20, 2024) to a high of $0.4850 (Jul 10, 2024), with a median of $0.4247 per EA.
Are there cheaper alternatives to ACETAMINOPHEN-COD #4 TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ACETAMINOPHEN-COD #4 TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ACETAMINOPHEN-COD #4 TABLET?
ACETAMINOPHEN-COD #4 TABLET (NDC 64380044702) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.